Chrysophanic Acid

CAS No. 481-74-3

Chrysophanic Acid( Chrysophanic Acid | NSC 37132 | NSC 646567 | Turkey Rhubarb )

Catalog No. M14613 CAS No. 481-74-3

Extracted from Rheum palmatum L.;Suitability:Boiling ethanol,benzene,chloroform,ether,acetic acid and acetone.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 30 In Stock
100MG 45 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Chrysophanic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Extracted from Rheum palmatum L.;Suitability:Boiling ethanol,benzene,chloroform,ether,acetic acid and acetone.
  • Description
    Extracted from Rheum palmatum L.;Suitability:Boiling ethanol,benzene,chloroform,ether,acetic acid and acetone;Store the product in sealed,cool and dry condition.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Chrysophanic Acid | NSC 37132 | NSC 646567 | Turkey Rhubarb
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    481-74-3
  • Formula Weight
    254.24
  • Molecular Formula
    C15H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 5 mg/mL warmed (19.66 mM)
  • SMILES
    O=C1C2=C(C=CC=C2O)C(C3=CC(C)=CC(O)=C13)=O
  • Chemical Name
    1,8-dihydroxy-3-methylanthracene-9,10-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lee MS, et al. PhytOthers Res, 2011, 25(6), 833-837.
molnova catalog
related products
  • EGFR-IN-9

    EGFR-IN-9 is a potent EGFR kinase inhibitor with IC50s of 7 nM, 28 nM for the wild type EGFR kinase and double mutant EGFR kinase (L858R/T790M). EGFR-IN-9 has antitumor activity.

  • Lazertinib

    Lazertinib (YH25448, GNS-1480) is a highly potent, mutant-selective, irreversible, brain-penetrant and orally active EGFR tyrosine-kinase inhibitors for both the T790M mutation and activating EGFR mutations.

  • Erlotinib mesylate

    Erlotinib (CP-358774;OSI-774;NSC 718781) is a potent, selective inhibitor of EGFR with IC50 of 2 nM.